FIELD: chemistry.
SUBSTANCE: invention relates to methods of obtaining a compound of formula (4), which can be used as a serine protease inhibitor.
EFFECT: protease inhibitors are useful for treatment HCV infections.
7 cl, 16 ex
Title | Year | Author | Number |
---|---|---|---|
MODULATORS OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE | 2007 |
|
RU2459821C2 |
METHODS AND INTERMEDIATE PRODUCTS | 2006 |
|
RU2446171C2 |
HETEROCYCLIC MODULATORS OF ATP-BINDING CARTRIDGE TRANSPORTER | 2006 |
|
RU2463303C2 |
HETEROCYCLIC MODULATORS OF TRANSPORTERS OF AN ATP-BINDING CASSETTE | 2016 |
|
RU2765714C2 |
HETEROCYCLIC MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS | 2012 |
|
RU2608610C2 |
PPAR-SUPPORTING COMPOUNDS FOR TREATING METABOLIC DISEASES | 2014 |
|
RU2687490C2 |
SERINE PROTEASE INHIBITORS | 2006 |
|
RU2441020C2 |
SYNTHESIS OF THIAZOLIDINEDIONE COMPOUNDS | 2011 |
|
RU2594725C2 |
THIAZOLIDINEDIONE SALTS WITH REDUCED AFFINITY TO PPAR FOR TREATMENT OF METABOLIC DISORDERS | 2010 |
|
RU2564661C2 |
NEW METHOD FOR SYNTHESIS OF THIAZOLIDINEDIONE COMPOUNDS | 2011 |
|
RU2593370C2 |
Authors
Dates
2014-10-20—Published
2010-04-27—Filed